Buy these 2 undervalued ASX shares in December, says expert

Experts say these businesses are far too cheap.

| More on:
Two happy shoppers finding bargains amongst clothes on a store rack

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

I believe it's always possible to find opportunities in the ASX share market as company share prices constantly fluctuate.

And if a company can beat the market's return, then it could be worth owning, in my view.

The more undervalued a business is, the higher the return could be or the higher the margin of safety we're giving ourselves.  

Here are two ASX shares the broker UBS considers undervalued and rates as buys. Let's get into it.

Siteminder Ltd (ASX: SDR)

UBS currently rates hotel software provider Siteminder as a buy, with a price target of $6.20. A price target suggests where the broker thinks the business will be trading in 12 months from the time of the investment call on the company.

The broker expects Siteminder's revenue to rise 24% in FY25 and 23% in FY26. A business growing revenue at that pace could be an appealing investment option.

Based on the company's FY24 results, UBS sees "good growth potential from new products" and product enhancements. The broker also expects Siteminder to "gain efficiencies in new markets and product segments."

Detailing why the underlying business was performing well, UBS said:

In our view, the underlying business continues to track well, with a focus on adding larger hotels, growing share of customer wallet, increasing Transaction penetration and a pipeline of new product launches to potentially support targeted 30% org[anic] annual rev[enue] growth [in the] medium-term.

By FY29, UBS expects the ASX share to generate $485 million in revenue and $61 million in net profit after tax (NPAT).

Select Harvests Ltd (ASX: SHV)

Select Harvests is one of Australia's largest almond producers. It grows almonds in seven regions across southern New South Wales, northern Victoria and eastern South Australia and has food processing facilities.

UBS rates Select Harvests as a buy, with a price target of $4.40.

The broker believes that the almond price outlook is promising, with price momentum looking "set to persist". It predicts the almond price will be $8.50 per kilo, up from its forecast of $8.10 in FY25 and $8.20 per kilo in FY26.

This is more than market expectations, with the long-term average at $8 per kilo.

UBS pointed to very positive recent industry feedback in its optimistic thoughts about the ASX share:

Our recent industry discussions regarding the Californian almond sector have been the most positive for SHV in years: 1) Downside risk to 2.8b lbs Californian Objective Estimate to potentially ~2.65b lbs, based on light supply coming from the South Valley, crop quality issues and elevated heat levels; 2) Liquidity issues among growers, leading to cuts to input purchases (fertiliser, water), with an expectation for grower default rates to pick up early 2025; 3) Crop pull outs exceeding new plantings, including young trees (as opposed to older trees), driven by the impact from SGMA groundwater regulation.

Based on UBS estimates, the ASX share's net profit could rise 70% in FY26, leading to earnings per share (EPS) of 29 cents. That would put the Select Harvests share price at less than 15x FY26's estimated earnings.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended SiteMinder. The Motley Fool Australia has positions in and has recommended SiteMinder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Unsure man analysing data on laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was an unhappy Thursday for ASX investors.

Read more »

Doctor checking patient's spine x-ray image.
Opinions

Pro Medicus shares drop 7%: falling knife or buying opportunity?

The healthcare tech company has had a painful March.

Read more »

Shot of a young businesswoman looking stressed out while working in an office.
Share Fallers

Why Domain, Mesoblast, Pro Medicus, and Tuas shares are tumbling today

These shares are having a tough time on Thursday. But why?

Read more »

Delighted adult man, working on a company slogan, on his laptop.
Technology Shares

Up 38% in 2025, why this ASX 200 tech stock could surge another 39%!

A top broker expects more strong outperformance from this surging ASX 200 tech stock.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Core Lithium, Healius, Neuren, and Reject Shop shares are storming higher today

These shares are avoiding the market weakness on Thursday. But why?

Read more »

Woman holding gold bar and cheering.
Gold

Up 50% in a month, why is this ASX All Ords gold stock surging again on Thursday?

The ASX All Ords gold miner is surging on Thursday even as the market sinks. But why?

Read more »

Two happy excited friends in euphoria mood after winning in a bet with a smartphone in hand.
Share Market News

Core Lithium shares race 5% higher on big news

What is getting investors excited on Thursday? Let's find out.

Read more »

Man with rocket wings which have flames coming out of them.
Mergers & Acquisitions

Guess which ASX stock is up 100%+ on takeover deal

This share is catching the eye on Thursday. Let's see what is happening.

Read more »